BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 18, 2021
View Archived Issues
PureTech advances its wholly owned pipeline
Read More
Phase II results presented for ZYN-002 in children and adolescents with DEE
Read More
BriaCell advances personalized immunotherapies for prostate cancer, melanoma and lung cancer
Read More
FDA accepts IND for phase I trial of Xilio's XTX-101 in solid tumors
Read More
Algernon plans phase I study of AP-188 for stroke
Read More
Akaal reports preclinical data on AK-119 in neuropathic pain
Read More
Modus collaborates with Imperial College London on clinical study of sevuparin in malaria
Read More
Harbour BioMed begins phase I dosing with HBM-4003 in NSCLC
Read More
Satsuma reports phase I safety and PK data on STS-101
Read More
4SC and NKI collaborate to study neoadjuvant domatinostat in urothelial carcinoma
Read More
Amgen synthesizes new fatty acid desaturase 1 inhibitors
Read More
Daewoong Pharmaceutical patents JAK3 inhibitors
Read More
Aurigene Discovery Technologies presents new CD73 inhibitors
Read More
Chinese investigators describe new JAK inhibitors
Read More
Alnylam Pharmaceuticals divulges ATXN3-targeting ds-siRNAs
Read More
Phase I data for the novel first-in-class anti-SIRPalpha antibody, BI-765063
Read More
177Lu-DOTAGA.(SA.FAPi)2 use for thyroid cancer
Read More
Viking reports phase I data on TRbeta agonist VK-0214
Read More
New basket trial evaluates spartalizumab in tumors with high PD-1 expression levels
Read More
Reversible BTK inhibitors from Hyperway described
Read More
HSV-targeting compound affects latent infection
Read More
Anji licenses rights to MCL1 inhibitor program from Broad Institute
Read More
Histopathology data reported for TATX-03a in SARS-CoV-2 challenged hamsters
Read More
Kite and ShoreLine Biosciences partner on allogeneic cell therapies for hematologic malignancies
Read More
Qpex opens phase I study of QPX-9003 for infections caused by drug-resistant Gram-negative pathogens
Read More
Evaluation of DAN-222 alone or in combination with PARP inhibitor in models of breast cancer
Read More
Increased PARP activity in PBLs could predict prostate cancer susceptibility
Read More